Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $97,217 - $118,144
-370 Reduced 10.45%
3,170 $985 Million
Q1 2024

Apr 11, 2024

SELL
$268.87 - $324.56 $126,368 - $152,543
-470 Reduced 11.72%
3,540 $1.01 Billion
Q4 2023

Jan 16, 2024

BUY
$255.7 - $288.46 $12,785 - $14,422
50 Added 1.26%
4,010 $1.15 Billion
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $865,854 - $1.07 Million
3,960 New
3,960 $1.06 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Financiere Des Professionnels Fonds D,Investissement Inc. Portfolio

Follow Financiere Des Professionnels Fonds D,Investissement Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financiere Des Professionnels Fonds D,Investissement Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financiere Des Professionnels Fonds D,Investissement Inc. with notifications on news.